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Abstract:  An  apoptosis  correlated  molecule—protein  Latcripin-1  of  Lentinula  edodes 
C913—was expressed and characterized in Pichia pastoris GS115. The total RNA was 
obtained from Lentinula edodes C91–3. According to the transcriptome, the full-length gene 
of Latcripin-1 was isolated with 3'-Full Rapid Amplification of cDNA Ends (RACE) and  
5'-Full RACE methods. The full-length gene was inserted into the secretory expression 
vector  pPIC9K.  The  protein  Latcripin-1  was  expressed  in  Pichia  pastoris  GS115  and 
analyzed by Sodium Dodecylsulfonate Polyacrylate Gel Electrophoresis (SDS-PAGE) and 
Western blot. The Western blot showed that the protein was expressed successfully. The 
biological function of protein Latcripin-1 on A549 cells was studied with flow cytometry 
and  the  3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl-tetrazolium  Bromide  (MTT)  method. 
The toxic effect of protein Latcripin-1 was detected with the MTT method by co-culturing 
the characterized protein with chick embryo fibroblasts. The MTT assay results showed 
that there was a great difference between protein Latcripin-1 groups and the control group  
(p  <  0.05).  There  was  no  toxic  effect  of  the  characterized  protein  on  chick  embryo 
fibroblasts. The flow cytometry showed that there was a significant difference between  
the  protein  groups  of  interest  and  the  control  group  according  to  apoptosis  function  
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(p  <  0.05).  At  the  same  time,  cell  ultrastructure  observed  by  transmission  electron 
microscopy supported the results of flow cytometry. The work demonstrates that protein 
Latcripin-1 can induce apoptosis of human lung cancer cells A549 and brings new insights 
into and advantages to finding anti-tumor proteins. 
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1. Introduction 
Throughout the world, cancer is one of the most serious diseases threatening the health of human 
beings [1–5]. It has become an urgent task to search for new drugs which have fewer side effects and 
which directly improve the survival rate of patients in the long term [6,7]. Lentinula edodes C91–3 is an 
edible  mushroom  isolated  from  Basidiomycetes  Umbelliferae  fungi.  Since  1991,  according  to  the 
international study of pharmaceutical research for Lentinula Edodes, six strains of mycels of Lentinula 
edodes have been fermented with the fermentation technology of bioengineering. One of the strain’s 
fermentation broths was found to have a direct anti-tumor effect [8,9]. Because the strain was studied 
beginning in March 1991, it was named as ―C91–3‖. ―C‖ represents ―China‖. The extracts contain a 
variety of proteins in addition to polysaccharides and amino acids [10–12]. The in vivo and in vitro 
experiments confirmed that some of the protein components have significant effects on inducing cell 
apoptosis [10,13]. According to the transcriptome sequence, we designed primers and used the 3'-Full 
RACE and 5'-Full RACE methods to produce the full-length gene. We induced and expressed the 
protein with the Pichia pastoris expression system and incubated the human lung cancer cell A549 
with the identified protein. The biological function of protein Latcripin-1 on A549 cells was studied 
with flow cytometry and the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl-tetrazolium Bromide (MTT) 
method. Finally, we analyzed whether the protein had the function of inducing apoptosis. 
2. Results and Discussion 
2.1. CDS Region of Lentinula edodes C91–3 Latcripin-1 Full-Length Gene 
To test the anti-tumor protein in Lentinula edodes C91–3, the total RNA of Lentinula edodes C91–3 
was extracted and a cDNA library was prepared. The short reads were obtained by using the Solexa  
High-flux  Sequencing  Technique.  These  short  reads  were  assembled  de  novo  with  the  sequence 
assembly software SOAP2. The output was the Unigene sequences, which could not be extended at 
both ends. At the same time, the given information was parsed and the gene function was annotated [14]. 
The Unigene sequences were blasted with the blastx method. All of the information on the Lentinula 
edodes  C91–3  transcriptome  was  obtained.  Latcripin-1  was  found  to  have  an  apoptosis  correlated 
function in the Cluster of Orthologous  Groups  of proteins (COG) database (COG-ID: COG5032). 
According to the preliminary results of the gene functional annotation, the domains were analyzed 
using  the  online  tools  Sanger  Pfam.  Finally,  the  apoptosis  correlated  molecule-Latcripin-1  was 
screened  out  of  Unigene  sequences.  Latcripin-1  was  named  from  three  words:  Lentinula  edodes, 
transcriptome and protein. The stem ―La tcri pin‖ represented the novel molecule. Int. J. Mol. Sci. 2012, 13  6248 
 
 
Three microliters of Total RNA of Lentinula edodes C91–3 and 5 μL of marker were added into 1% 
agarose gel. It was indicated that the total RNA was complete (Figure 1a). After the 3'-Full RACE 
reaction, 5 μL Inner Polymerase Chain Reaction (PCR) product and 5 μL marker were added into 1.5% 
agarose gel. A clear band was visible at 500 bp (Figure 1b). After the 5'-Full RACE reaction, 5 μL 
Inner PCR product  and 5 μL marker were  added to  1.5% agarose  gel. A clear band appeared at  
1800 bp, while no bands appeared in the M-MLV (−) control group (Figure 1c). After the RT-PCR 
reaction with primer F and primer R, 5 μL RT-PCR product and 5 μL marker were added to 1.0% 
agarose gel for electrophoresis. Above 3000 bp a clear band was shown. The band size was consistent 
with the sequencing results, while there were no bands in the M-MLV (−) control group (Figure 1d). 
The Lentinula edodes C91–3 Latcripin-1 full-length gene Coding Sequence (CDS) region is as follows 
(Figure 2) (GenBank Accession Number: JQ327159). The amino acid sequence of protein Latcripin-1 
was obtained according to the gene sequence (Figure 2). 
Figure 1. The results of agarose gel electrophoresis. (a) Total RNA of Lentinula edodes 
C91–3. M: DNA Marker DL2000. 1: total RNA of Lentinula edodes C91–3. (b) 3'-Full RACE 
reaction of Latcripin-1 gene. M: DNA Marker DL2000. 1: product of 3'-Full RACE inner 
PCR. (c) 5'-Full RACE reaction of Latcripin-1 gene. M: DNA Marker DL2000. 1: product 
of  5'-Full  RACE  inner  PCR  (M-MLV(−)).  2:  product  of  5'-Full  RACE  inner  PCR  
(M-MLV (+)). (d) Full-length of Latcripin-1 gene. M: DNA Marker λ-Hind III digest.  
1: product of RT-PCR (M-MLV (−)). 2: product of RT-PCR (M-MLV (+)). 
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Figure 2. The full-length CDS region of Lentinula edodes C91–3 Latcripin-1 gene and the 
amino acid sequence. 
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2.2. Amino Acid Sequence Analysis of Protein Latcripin-1 
The general amino acid analysis of protein Latcripin-1 was done by DNAStar software [15] (Figure 3). 
The  secondary  structure  of  protein  Latcripin-1  was  analyzed  with  the  Swiss-Model  database  [16] 
(Figure 4) and the Pfam database [17]. The results showed that three Pfam-A matched to the search 
sequence (all significant) (Figure 5a). The location of the amino acids spanning the different domains 
is shown in Figure 5b. After that, the tertiary structure of protein Latcripin-1 was predicted using 
homology  structure  modeling  on  the  Swiss-Model  server  [16].  The  tertiary  structure  of  protein 
Latcripin-1  is  between  the  Target  of  Rapamycin  (TOR)  and  Phosphatidylinositol  3-kinase  (PI3K) 
superfamily. There is a kinase domain in C-terminal, which is similar to the catalytic domain of PI3K 
(Figure  5c2).  A  FAT  (for  FRAP,  ATM,  TRAP)  domain  exists  in  other  PIKK  proteins  families 
upstream  of  the  kinase  domain  (Figure  5c1).  At  the  end  of  the  C-terminal,  there  is  another FAT 
structure territory, called FATC (for FRAP, ATM, TRAP in C-terminal end) (Figure 5c3). Models of the 
functional domain of protein Latcripin-1 were colored from blue (N terminus) to red (C terminus). The 
modeling parameters are shown in Table 1. At the same time, the cladogram depicting of protein 
Latcripin-1  was  analyzed  with  the  multiple  sequence  alignment  program  ClustalW2.  The  similar 
proteins  from  Serpula,  Schizophyllum  and  Coprinopsis  species  (Identity  >  50%)  were  aligned  
(Figure 5d). Protein Latcripin-1 is more homologous to Serpula species than to the other two. 
Figure 3. The general amino acid analysis of protein Latcripin-1. 
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Figure 4. The secondary structure of protein Latcripin-1. H: helix; E: extended-beta; C: coil. 
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Figure 5. (a) The structural domain analysis of protein Latcripin-1 with Pfam database 
(Significant  Pfam-A  Matches).  (b)  The  location  of  the  amino  acids  structural  domain.  
(c) The tertiary structure of protein Latcripin-1. (1) FAT domain; (2) PI3K kinase domain; 
(3) FATC domain. (d) The cladogram depicting of protein Latcripin-1. 
 
a 
 
b 
 
c 
 
d 
Table 1. The modeling parameters and modeling information. 
 
Modeled 
Residue Range 
Based on 
Template 
Sequence 
Identity (%) 
E Value  Modeling Information 
FAT  149 to 509  1w3bA  10.11  5.10 ×  10
−9 
The superhelical TPR domain of O-linked 
glcnac transferase reveals structural 
similarities to importin alpha 
PI3K  541 to 978  1he8A  17.70  8.10 ×  10
−42  Ras G12V-PI 3-Kinase gamma complex 
FATC  1040 to 1070  1w1nA  34.38  4.70 ×  10
−9 
The solution structure of the FATC domain 
of the protein kinase TOR1 from yeast 
2.3. Transformation of Pichia pastoris GS115 and Selection of Transformants 
After PCR amplification, 5 μL PCR reaction solution was taken for 1.0% agarose gel electrophoresis. 
A 1200 bp band was seen in the GS115–pPIC9K/Latcripin-1 group. In the GS115–pPIC9K group  Int. J. Mol. Sci. 2012, 13  6253 
 
 
500  bp  and  2200  bp  bands  were  seen.  There  was  no  band  in  the  GS115–pPIC9K  group  when  
gene-specific  primers  were  used  (Figure  6).  The  second  characterized  GS115–pPIC9K/Latcripin-1 
clone was selected at random for further work. 
Figure 6. Selection of transformants. 1–8: GS115–pPIC9K/Latcripin-1 clone (R1seq primer 
and 5'AOX I primer). M: DL2000 DNA Marker. 9: GS115–pPIC9K clone (R1seq primer 
and 5'AOX I primer). 10–16: GS115- pPIC9K clone (3'AOX I primer and 5'AOX I primer). 
 
2.4. Expression and Characterization of Protein Latcripin-1 in Pichia pastoris GS115 
Supernatants  on  different  time spans  (24 h, 48 h, 72 h, 96 h) were collected  and  analyzed  by  
Sodium  Dodecylsulfonate  Polyacrylate  Gel  Electrophoresis  (SDS-PAGE)  (Figure  7).  The  sample 
volume was 25 μL and the marker volume was 5 μL. GS115–pPIC9K was used as a negative control. 
It was shown that the target protein appeared from 24 h until 96 h at 118 kda, while no interesting 
protein appeared in the negative control supernatant (96 h). 
Figure  7.  Sodium  Dodecylsulfonate  Polyacrylate  Gel  Electrophoresis  (SDS-PAGE)  of 
supernatants  in  different  time  spans.  M:  Protein  Molecular  Weight  Marker  (Broad).  
1: supernatants of GS115–Latcripin-1 (24 h). 2: supernatants of GS115–pPIC9K (96 h). 3,4: 
supernatants  of  GS115–Latcripin-1  (96  h).  5,6:  supernatants  of  GS115-Latcripin-1  
(72 h). 7,8: supernatants of GS115–Latcripin-1 (48 h). 
 
To characterize the expressed protein, the Western blot method was used, the results of which are 
demonstrated in Figure 8. Anti-His-Tag positive bands appeared in the position of 118 kda. No band 
appeared in the negative control group. Int. J. Mol. Sci. 2012, 13  6254 
 
 
Figure 8. Western blot of protein Latcripin-1 in different time spans. M: Precision Plus 
Protein Standards Dual color (with 6×  His tag). 1,2: supernatants of GS115–Latcripin-1  
(96  h).  3,4:  supernatants  of  GS115–Latcripin-1  (72  h).  5,6:  supernatants  of  
GS115–Latcripin-1 (48 h). 7: supernatants of GS115–Latcripin-1 (24 h). 8: supernatants of 
GS115–pPIC9K (96 h). 
 
2.5. Affinity Purification of Protein Latcripin-1 from Pichia pastoris Culture Supernatant 
The supernatant that cultured for 96 h was freeze-dried. The freeze-dried supernatant was dissolved 
into 20 mL pure water to be purified. Five milliliters resuspended protein was added to each column, 
respectively. The fractions of 5 mL Soluble Elution Buffer were collected into 5 Eppendorf tubes 
(1.5 mL)  and  analyzed  by  SDS-PAGE  (Figure  9).  Finally,  the  purified  protein  was  diluted  into 
7.5 μg/mL, 15 μg/mL and 30 μg/mL for biological functional identification. 
Figure  9.  Affinity purification of protein Latcripin-1. M: PageRuler Prestained Protein 
Ladder. 1: blank control. 2,3: culture supernatants induced for 96 h. 4: the first 1 mL eluted 
fraction. 5: the second 1 mL eluted fraction. 6: the third 1 mL eluted fraction. 7: the fourth 
1 mL eluted fraction. 8: the fifth 1 mL eluted fraction. 
 
2.6. Effects of Protein Latcripin-1 on the Proliferation and Apoptosis of Lung Cancer A549 Cells 
2.6.1. MTT assay of Protein Latcripin-1 on Human Lung Cancer Cell A549 
After 24 h of incubation, the cell inhibition of the purified protein group was higher than that of the 
control group. The difference of the OD492 nm value was significant (Figure 10). The growth of 
cancer cells A549 was inhibited significantly by protein Latcripin-1. In addition, the inhibition level of 
protein Latcripin-1 under different concentrations was higher than that of 5 μg/mL DDP (Cisplatin). 
We  can  see  that  the  inhibiting  function  of  protein  Latcripin-1  on  A549  cells  was  time  and 
concentration dependent. Int. J. Mol. Sci. 2012, 13  6255 
 
 
Figure 10. OD492 nm value of protein Latcripin-1 (LP-1) in different time spans of the 
MTT assay. * negative control group, p < 0.05.   Five μg/mL DDP group, p < 0.05. 
 
2.6.2. Apoptosis Function Detection of Protein Latcripin-1 on Human Lung Cancer Cells A549 
After 24 h of incubation, the A549 cells were stained with the Annexin/PI double staining method. 
The cell apoptosis rate was measured by flow cytometry in triplicate with the Cell Quest software [18] 
analysis  and  detection  system  (Figure  11a,b).  In  Figure  11a,  the  upper  right  quadrant  shows  the 
advanced stage apoptotic cells. The lower right quadrant shows early stage apoptotic cells. The upper 
left quadrant shows dead cells. The lower left quadrant shows normal cells. The results illustrate that 
when  the  concentration  was  increased  to  30  μg/mL,  the  inducing  apoptosis  function  of  protein 
Latcripin-1 increased simultaneously. Under the interaction of protein Latcripin-1, the tolerance to 
physical and chemical effects of A549 cell was decreased, the cell debris was increased and the dead 
cells were increased significantly. 
Figure 11. (A) The apoptosis rate of protein Latcripin-1 on A549 cell, (a) negative control 
group, (b) 7.5 μg/mL protein Latcripin-1 group, (c) 15 μg/mL protein Latcripin-1 group,  
(d) 30 μg/mL protein Latcripin-1 group; (B) The apoptosis rate of the expressed protein 
Latcripin-1 (LP-1) on A549 cell (%). * negative control, p < 0.05. 
(A) 
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Figure 11. Cont. 
(B) 
 
2.6.3. Changes of Cell Ultrastructure Observed by Transmission Electron Microscopy (TEM) 
TEM  analysis  exhibited  different  morphological  alterations  in
  A549  cells  after  treatment  with 
protein Latcripin-1 (30 μg/mL) for 24 h (Figure 12). In the control group (Figure 12a), A549 cells 
maintained regular morphology with a large nucleus (black arrow), many mitochondria (white arrow), 
and membrane phase structural integrity (arrowhead). However, increase of intracytoplasmic vacuoles 
(arrowhead), chromatin condensation, nuclear fragmentation (black arrow), and mitochondrial swelling 
(white arrow) were observed in treated A549 cells (Figure 12b). 
Figure 12. Electron micrographs of A549 cells. Magnification 8000× ; TEM. (a) Cells of 
control group; and (b) cells treated with Protein Latcripin-1 (30 μg/mL) for 24 h. 
 
2.7. The Toxicity Test of Protein Latcripin-1 on Normal Chick Embryo Fibroblasts 
The toxicity test results of protein Latcripin-1 on normal chick embryo fibroblasts (OD492 value,  
x ±  s) are shown in Figure 13. The growth of chick embryo fibroblasts was not inhibited with different 
concentrations of protein Latcripin-1. The difference was not significant compared with the negative Int. J. Mol. Sci. 2012, 13  6257 
 
 
control group. The cells were inhibited with 5 μg/mL DDP in the first 24 h of incubation. The difference 
was significant compared with the protein Latcripin-1 and negative control groups (p < 0.05). 
Figure 13. The toxic effect of protein Latcripin-1 (LP-1) on normal chick embryo fibroblasts 
in different time spans. * protein Latcripin-1 and negative control groups, p < 0.05. 
 
2.8. Discussion 
In this experiment, pPIC9K was chosen as the carrier. There is a strong promoter (AOXI) in it. 
With the promoter, pPIC9K can express the extraneous protein effectively under the induction of 
methanol [19–21]. pPIC9K is a shuttle plasmid. It cannot only replicate in prokaryotic cells, but can 
also be expressed in eukaryotic cells, which is convenient for experiments. The recipient strain used in 
this experiment is GS115, established by Cregg [22], which has the histidine dehydrogenase-deficient 
gene His4 (encoding histidine dehydrogenase gene). It can accept a vector with the His4 gene and turn  
into  His+  phenotype  transformants,  and  therefore  can  be  screened  in  the  histidine-deficient  MD  
culture medium. 
This is our first attempt to express the protein of Lentinula edodes C91–3 with the yeast expression 
system. Pichia pastoris has been well developed in recent years [23]. It is a methanol nutrition yeast 
expression system  and  is  widely used for  expressing extraneous  proteins. As a type of  eukaryon, 
Pichia pastoris not only can induce correct translation and post-processing of the extraneous eukaryon 
genes, but also has the function of modifying N- or O-glycosylation of the secreted protein. Recently, 
more  and  more  exogenous  genes  were  expressed  successfully  with  this  expression  system:  tumor 
necrosis factor [24], epidermal growth factor [25], human p53 protein [26], human serum albumin [27–29], 
human vascular endothelial cell growth factor [30] and human pro-insulin [31,32]. Results show that 
protein Latcripin-1 expressed through this system has high biological activity, which proves that the 
yeast expression system is suitable for the expression of fungus proteins. 
This is also the first time we have separated the apoptosis-related proteins from Lentinula edodes 
C91–3.  Apoptosis  is  an  initiated  death  process  during  the  cell  ontogenesis  process.  The  process  is 
regulated by a series of proteins [33]. Through analyzing the protein domain of the Latcripin-1 gene, 
we found that the protein’s tertiary structure is very special. The structure is between TOR (target of 
rapamycin)  and  PI3K  (phosphatidylinositol-3-kinase).  There  is  a  kinase  domain  in  the  C-terminal 
similar  to  the  catalytic  domain  of  PI3K.  A  FAT  domain  exists  in  other  PIKK  proteins  families Int. J. Mol. Sci. 2012, 13  6258 
 
 
upstream of the kinase domain. PI3Ks are a family of enzymes involved in cellular functions such as 
cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn 
are  involved  in  cancer.  In  response  to  lipopolysaccharide,  PI3K  phosphorylates  p65  induce 
anandamide  synthesis  to  inhibit  NF-κB  activation.  This  is  under  the  control  of  fatty  acid  amide 
hydrolase (FAAH). FAAH can limit the ability of lipase to increase AEA. This is also inhibited by 
wortmannin and cannabidiol, which are two of the only natural compounds to inhibit FAAH [34–36]. 
Many PIK-related proteins are involved in cell-cycle checkpoint controls (e.g., ATM, ATR, DNA-PK, 
ESR1  and  Rad  3).  Dysfunction  can  result  in  a  range  of  diseases,  including  immunodeficiency, 
neurological disorder and cancer [37]. Also, it has been reported that the main pathways related to the 
pathogenesis  of  lung  cancer  are  the  PI3K/Akt-mTOR  pathway  and  the  Ras-Raf-MEK/ERK  
pathway [38]. At the end of the C-terminal, there is a FATC structure, which is considered to interact 
with the FAT to expose the kinase domain [39,40]. The FAT domain is named after FRAP, ATM and 
TRRAP.  It  mediates  signaling  through  Grb2  via  phosphorylated  Y925.  Bosotti  [37]  reported  two 
crystal structures of the FAT domain. Large rearrangements of the structure are indicated to allow 
phosphorylation of Y925 and subsequent interaction with Grb2. The FATC domain is named after 
FRAP, ATM, TRRAP C-terminal [37]. The FAT domain is only present in the FRAP, ATM and 
TRRAP subfamilies and always coexists with the FATC domain [37]. The solution structure of the 
FATC domain suggests it plays a role in redox-dependent structural and cellular stability [41]. 
Thus, we speculated that such a molecular structure augments its biological activity in some aspect. 
It  can  also  be seen  from  Figures  10, 11, 12 that  the  biological  function  of protein  Latcripin-1  is 
significant. A549 cells were markedly induced to apoptosis. It was interesting to note that there was no 
toxic effect of the characterized protein on chick embryo fibroblasts. We hypothesized that there was 
no recognition site of protein Latcripin-1 in the chick embryo fibroblasts. However, further research is 
required to prove these hypotheses. At the same time, further research is required to elucidate the 
relationship of these functional domains. The improved understanding of these functional domains will 
potentially provide further understanding of the apoptosis mechanism of protein Latcripin-1. 
3. Experimental Section 
3.1. Strains, Plasmids, and Reagents 
The Escherichia coli strain DH5a, used as the host for cloning the gene Latcripin-1, was equipped 
in  our  laboratory.  The  pPIC9K  vector  and  the  Pichia  pastoris  strain  GS115  (his-mut+),  used  for 
protein Latcripin-1 expression, were from Invitrogen Co. (Beijing, China). The In-Fusion
TM Advantage 
PCR Cloning Kit, 3'-Full RACE Core Set Ver2.0, 5'-Full RACE Kit, BigDye Terminater V3.1 Cycle 
Sequencing Kit, Plasmid purification kit, Lysis Buffer for Microorganism to Direct PCR, restriction 
polymerases  and  Primers  were  from  Takara  (Dalian,  China).  Trizol,  Penta.  His  Antibody  and  
HRP-Rabbit Anti-Mouse IgG (H + L) were from Invitrogen Co. (Beijing, China). Bicinchoninic Acid 
Kit for Protein Determination was from Sigma-Aldrich Trading Co., Ltd (Shanghai, China). Annexin  
V-FITC  /PI  kit  was  from  Becton  Dickinson  Medical  Devices  Co.,  Ltd  (Shanghai,  China).  The 
integrated potato culture medium was prepared by our own laboratory. Int. J. Mol. Sci. 2012, 13  6259 
 
 
3.2. Method of Getting the CDS Region of Lentinula edodes C91–3 Latcripin-1 Full-Length Gene 
The mycelium of Lentinula edodes C91–3 was cultured with integrated potato culture medium for  
18 days in a mortar. It was then tritumed with liquid nitrogen. Total RNA was extracted with Trizol 
reagent. The obtained RNA was dissolved in 50 μL DEPC treated water. Primers of 3'-RACE and  
5'-RACE experiments were designed with oligo6.0 software according to the transcriptome sequence 
results, all primers required for the experiments are listed as follows (Table 2). 
Table 2. Primers used in the experiment. 
Primer Name   Primer Sequence (5'→3')  Length (bp) 
3'-RACE Outer Primer 1  TACCGTCGTTCCACTAGTGATTT  23 
3'-RACE Outer Primer 2   CACCGGTGTGGAAGGCGTATT  21 
3'-RACE Inner Primer 1   CGCGGATCCTCCACTAGTGATTTCACTATAGG  32 
3'-RACE Inner Primer 2   TAGATGCCAGGGACCGCTTCT  21 
5'-RACE Outer Primer 1   CATGGCTACATGCTGACAGCCTA  23 
5'-RACE Outer Primer 2   TCTTCGCCAGGGACCGTAGAT  21 
5'-RACE Inner Primer 1   CGCGGATCCACAGCCTACTGATGATCAGTCGATG  34 
5'-RACE Inner Primer 2   CTGAGCGTCGGTAGCATTTGC  21 
F Primer  CATGGAGAGTGCGAAACTAG  20 
R Primer  GAAATGCGGTAAACCACTTG  20 
Latcripin-1-R1seq primer   CAATAGGACCACCCAAAACC  20 
repair Primer1F  CATGGAGAGTGCGAAACTAG  20 
repair Primer1R  GAAATGCGGTAAACCACTTG   20 
repair Primer2F  CAAGTGGTTTACCGCATTTC  20 
repair Primer2R  ATGTTTGTCCGTCACTCCCG   20 
repair Primer3F  CGGGAGTGACGGACAAACAT  20 
repair Primer3R  TTGGTGAAGAGGTCCGCGGCTTTG  24 
5'-AOX I primer  GACTGGTTCCAATTGACAAGC  21 
3'-AOX I primer  GGCAAATGGCATTCTGACAT  20 
The results of 3'-Full RACE and 5'-Full RACE were sequenced and stitched. Afterwards, primer F 
and primer R were designed accordingly. The cDNA was synthesized with Tkara 3'-Full Race Core 
Ver.2.0. The M-MLV (−) control was established at the same time. SnaB I/Not I restriction sites were 
added  to  the  N-  and  C-terminal,  respectively,  in  order  to  implement  In-Fusion
TM  ligation  [42].  
A 6×  HIS tag was added at the 3'end for later characterization. The cDNA was amplified by PCR with 
primer F and primer R. The sequence of the amplified gene was analyzed and confirmed by ABI 
PRISMTM 3730XL DNA Sequencer and Applied Biosystem. 
3.3. Construction of Expression Vector Latcripin-1 
The yeast eukaryotic expression vector, plasmid pPIC9K, was cut by SnaB I/Not I in 100 μL system 
at 37 °C  for 4 h. The products were purified with Takara DNA Fragment Purification Kit Ver. 2.0, and 
then recycled with Takara Agarose Gel DNA Purification Kit Ver. 2.0. In order to identify, separate 
and  purify  the  protein,  a  6×   His-tag  was  added  at  the  end  of  Latcripin-1  gene.  We  used  an  
In-Fusion
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and  expression  vector.  The  constructed  plasmid  Latcripin-1  was  transformed  into  a  competent  
E. coli DH5a strain, which was spread on LB agar plates (pH 7.0) with 100 g/mL ampicillin and 
incubated  overnight.  The  expression  plasmid  Latcripin-1  was  obtained  from  the  screened  positive 
transformants and verified by both BamHI and NotI digestion. Sequencing was conducted at Takara 
Dalian Co. 
3.4. Transformation of Pichia pastoris GS115 and Selection of Transformants 
Pichia  pastoris  GS115  was  transformed  with  the  linearized  expression  vector  Latcripin-1  by 
digestion with SacI. After lectrotransformation, the transformant cells were plated on RDB plates, 
incubated at 30 °C  for 72 h. Meanwhile, a simple vector pPIC9K was transformed into Pichia pastoris 
GS115 as a negative control. The two different pastoris were named as GS115–pPIC9K/Latcripin-1 
and  GS115–pPIC9K,  respectively.  To  select  positive  clones  for  protein  expression,  eight  of  the 
GS115–Latcripin-1 colonies and seven GS115–pPIC9K clones were chosen and amplificated (Lysis 
Buffer  for  Microorganism  to  Direct  PCR,  TaKaRa  LA  Taq
TM  Kit).  The  primers  for  
GS115–pPIC9K/Latcripin-1 were Latcripin-1—R1seq primer (20 pm) and 5'AOX I primer (20 pm). 
For GS115-pPIC9K, 3'AOX I primer (20 pm) and 5'AOX I primer (20 pm) were used (Table 2). One 
characterized clone was selected at random for further work. 
3.5. Induction and Expression of Protein Latcripin-1 in Pichia pastoris GS115 
The  selected  recombinant  strains  (His+  Mut+)  that  were  integrated  with  Latcripin-1  and  with 
pPIC9K were cultured in 50 mL YPD  medium at 30 ° C and 1000 rpm until the OD600 reached 
approximately  2–6.  Then  0.4%  of  the  medium  was  chosen  and  transferred  into  100  mL  BMGY 
medium, cultured at 30 °C  and 1000 rpm until the OD600 reached approximately 2–6. To induce 
expression  of  the  protein  Latcripin-1,  100  mL  of  the  strains  were  harvested  by  centrifugation  at  
4000 rpm for five minutes and then resuspended to approximately 1.5 at OD600 in BMMY. Methanol 
was added to a final concentration of 1% every 24 h to maintain the induction.  One milliliter of 
supernatants was collected and centrifuged every 24 h. At the time point of 96 h, the supernatants were 
all collected for the extraction and analysis of the protein Latcripin-1. 
3.6. Characterization of Protein Latcripin-1 with Western Blot 
The supernatants were finally resuspended in 40 μL with 8 μL 1ￗ SDS Sample Buffer, incubated at 
95 °C  for 10 min, then centrifuged at 10,000 g for 5 min at room temperature. The denatured protein 
was analyzed by 10% SDS-PAGE. Then, the protein in the gel was transferred to a polyvinylidend 
difluoride membrane using a semi-dry electroblotting. The membrane was blocked, agitated, with 5% 
non-fat-milk at 25 °C  for 2 h. The first antibody’s (Penta. His Antibody) dilution was 1:1000, and the 
second  antibody’s  (HRP-Rabbit  Anti-Mouse  IgG)  dilution  was  the  same.  True  Blue  Peroxides 
Substrate was selected as the chromogenic substrate. All reaction conditions were at room temperature 
for 1 h. Int. J. Mol. Sci. 2012, 13  6261 
 
 
3.7. Affinity Purification of Protein Latcripin-1 from Pichia pastoris Culture Supernatant 
The  culture  supernatants  induced  for  96  h  were  freeze-dried  and  resuspended  to  20  mL  with 
deionized water. The Nickel Chelated Column was uncapped and the alcohol was allowed to drain 
from the gel bed. The gel was balanced by 8 mL binding buffer. Then the 5 mL resuspended protein 
was added to the column. The flow rate was controlled at 10 mL/h. After that, the column was washed 
with 15 mL binding buffer. The fractions were collected. Finally, the 6×  His-tagged protein was eluted 
with 5 mL elution buffer and the fractions were collected. The eluted fractions were measured by 10% 
SDS-PAGE and Microplate reader at 565 nm. The remaining 15 mL resuspended protein was purified 
with the same method. Then, Bicinchoninic Acid Kit for Protein Determination was used to measure 
the concentration of the purified protein [43]. 
3.8. Effects of Protein Latcripin-1 on the Proliferation and Apoptosis of Lung Cancer A549 Cells 
The Inhibition level of protein Latcripin-1 on A549 cell proliferation was determined by MTT assay. 
Annexin V-FITC and PI double staining were used to analyze apoptosis. Changes of cell ultrastructure 
were observed by transmission electron microscopy. 
A549 cells were grown in RPMI-1640 medium supplemented with 10% FBS (fetal bovine serum), 
incubated at 37 °C , in 5% CO2 condition in a carbon dioxide incubator. 
First, the logarithmic phase of A549 cells was plated in three 96-wells plates at the concentration of  
1 ×  10
5 cells/well, and then cultured in 10% FBS RPMI-1640. After 24 h incubation, the experiment 
was divided into five groups, each of which included three wells. Then the medium was replaced with 
the  same  kind  of  medium,  supplemented  with  different  concentrations  of  protein  Latcripin-1  
(7.5 μg/mL, 15 μg/mL and 30 μg/mL). Ten percent FBS RPMI-1640 was used as a negative control, 
while 5.0 μg/mL chemotherapeutics DDP was used as a positive control. After 24 h, 48 h and 72 h of 
incubation, respectively, the medium was discarded. The cells were incubated with 20 μL 10 mg/mL 
MTT at 37 °C  for 4 h. Then 150 μL DMSO (Dimethyl Sulfoxide) was added per well. The absorbance 
was detected at 492 nm on a plate reader.  
Second,  the  logarithmic  phase  of  A549  cells  was  plated  in  a  25  mL  culture  flask  of  
3  ×  10
5  cells/flask, and then cultured in  3 mL  10% FBS  RPMI-1640. After 24 h incubation,  the 
medium was replaced with the medium supplemented with 30 μg/mL protein Latcripin-1, 10% FBS 
RPMI-1640 was used as a negative control. After another 24 h of incubation, half of the cells were 
trypsinizated with 0.25% EDTA (Ethylenediamine Tetraacetic Acid)-trypsogen and washed with PBS 
three times. Annexin V-FITC /PI dye was added according to the instruction of the kit. First, 200 μL 
Binding Buffer was added. Then 10 μL Annexin V-FITC and 5 μL PI were added. After 15 min dark 
incubation, apoptosis function of protein Latcripin-1 was detected with flow cytometry and analyzed 
with  Cell  Quest  software  [18].  Finally,  the  other  half  of  the  cells  were  fixed  with  2%  glutaric 
dialdehyde and prepared for transmission electron microscopy. After having been fixed at 4 °C  for 24 
h, the cells were fixed with 1% osmic acid for 3 h. After washing, the cells were dehydrated by being 
placed in higher and higher concentrations of alcohol at 4 °C . Then, 100% acetone and embedding 
solution (2:1) were added at 25 °C  for 4 h. 100% acetone and embedding solution (1:2) were added at 
25 °C  for 12 h. Embedding solution was added at 37 °C  for 12 h, then incubated at 45 °C  for 12 h, and Int. J. Mol. Sci. 2012, 13  6262 
 
 
at 60 °C  for 24 h. When the embedding medium was hard, the sections were cut on an ultramicrotome. 
Then  the  sections  were  stained  with  3%  uranyl  acetate-lead  citrate.  The  cells’  ultrastructure  was 
observed with electron microscope. 
3.9. The Toxicity Test of Protein Latcripin-1 on Normal Chick Embryo Fibroblasts 
The  normal  chick  embryo  fibroblasts  were  prepared  in  96-well  plates  at  a  concentration  of  
1 ×  10
5 cells/well, cultured in 10% FBS RPMI-1640. After 24 h of incubation, the experiment was 
divided into  five groups, each of which included  three wells.  There were three  groups of  protein 
Latcripin-1  (7.5  μg/mL,  15  μg/mL  and  30  μg/mL).  Ten  percent  FBS  RPMI-1640  was  used  as  a 
negative control and 5.0 μg/mL DDP was used as a positive control. All of the components were 
prepared in 10% FBS RPMI-1640. After 24 h, 48 h and 72 h incubation, respectively, the cells were 
tested with the MTT method at 492 nm. 
3.10. Statistical Analysis 
SPSS10.0 software [44] was used for statistical analysis. Independent-samples T test was used to 
compare the differences between two groups. p < 0.05 was considered to be statistically significant 
between the two groups. 
4. Conclusions 
In conclusion, a novel apoptosis correlated molecule, protein Latcripin-1 from Lentinula edodes 
C91–3, was induced and expressed successfully by using a pPIC9K vector with an alcohol oxidase 1 
promoter in Pichia pastoris GS115. The protein can induce apoptosis in human lung cancer cells A549. 
Though further research is required to elucidate the apoptosis mechanism induced by protein Latcripin-1, 
it is the first time to find and study the new protein (GenBank Accession Number: JQ327159). The 
work brings new insights and advantages in finding anti-tumor proteins, and addresses the possibilities 
of solving screening or purification problems, which builds a foundation for further anti-tumor studies 
of Lentinula edodes C91–3. 
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